Literature DB >> 21546915

Characteristics of fine vascular network pattern associated with recurrence of polypoidal choroidal vasculopathy.

A Oishi1, M Mandai, M Kimakura, A Nishida, Y Kurimoto.   

Abstract

OBJECTIVE: To characterize an irregular capillary-like structure in the vascular network of eyes with polypoidal choroidal vasculopathy (PCV), and to determine whether its presence after photodynamic therapy (PDT) can be used to predict the clinical course of PCV.
METHODS: We reviewed the clinical records of 29 eyes of 29 patients with PCV, who underwent PDT and confocal retinal angiographic examinations every 3 months. The images obtained before the PDT were compared with those after the PDT. The correlations between angiography findings and recurrences were evaluated.
RESULTS: An area of fine, densely packed capillary-like vessels, named the fine vascular network, was identified within the polypoidal vascular network in 25 of 29 cases at the initial examination. The fine vascular network regressed in 23 cases (92%) after the first PDT. Thereafter, the fine vascular network remained or enlarged in 19 eyes, and 17 (84.5%) of these eyes had a recurrence of the polypoidal lesions or had exudative changes. In contrast, recurrences were found in only 2 of 10 (20%) eyes, whose fine network had regressed without a subsequent enlargement (P<0.001 compared with the former group).
CONCLUSIONS: A fine irregular vascular network is present in the majority of eyes with PCV before PDT. Its presence or expansion after PDT was significantly associated with a recurrence of PCV. Thus, we recommend that this network be monitored after treatment to determine whether a polypoidal vascular network will recur.

Entities:  

Mesh:

Year:  2011        PMID: 21546915      PMCID: PMC3178219          DOI: 10.1038/eye.2011.110

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

1.  Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy.

Authors:  Robert H Rosa; Janet L Davis; Charles W G Eifrig
Journal:  Arch Ophthalmol       Date:  2002-04

2.  Pathological features of surgically excised polypoidal choroidal vasculopathy membranes.

Authors:  Sachiko Kuroiwa; Hisashi Tateiwa; Toshio Hisatomi; Tatsuro Ishibashi; Nagahisa Yoshimura
Journal:  Clin Exp Ophthalmol       Date:  2004-06       Impact factor: 4.207

3.  Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.

Authors:  Taiichi Hikichi; Hideo Ohtsuka; Makoto Higuchi; Takuro Matsushita; Hiroko Ariga; Shoko Kosaka; Reiko Matsushita; Kimitaka Takami
Journal:  Am J Ophthalmol       Date:  2010-08-05       Impact factor: 5.258

4.  Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation.

Authors:  H Terasaki; Y Miyake; T Suzuki; M Nakamura; T Nagasaka
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

5.  Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study.

Authors:  A Okubo; M Sameshima; A Uemura; S Kanda; N Ohba
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

6.  Photodynamic therapy of polypoidal choroidal vasculopathy.

Authors:  Adam H Rogers; Paul B Greenberg; Adam Martidis; Carmen A Puliafito
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2003 Jan-Feb

7.  Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.

Authors:  Sung Chul Lee; Youl Seok Seong; Sung Soo Kim; Hyung Jun Koh; Oh Woong Kwon
Journal:  Ophthalmologica       Date:  2004 May-Jun       Impact factor: 3.250

8.  Treatment of polypoidal choroidal vasculopathy with photodynamic therapy.

Authors:  Richard F Spaide; Irene Donsoff; Deborah L Lam; Lawrence A Yannuzzi; Lee M Jampol; Jason Slakter; John Sorenson; K Bailey Freund
Journal:  Retina       Date:  2002-10       Impact factor: 4.256

9.  Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Authors:  Wai-Man Chan; Dennis S C Lam; Timothy Y Y Lai; David T L Liu; Kenneth K W Li; Yi Yao; Tak-Hung Wong
Journal:  Ophthalmology       Date:  2004-08       Impact factor: 12.079

10.  Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy.

Authors:  M-W Lee; I Yeo; D Wong; C-L Ang
Journal:  Eye (Lond)       Date:  2008-08-29       Impact factor: 3.775

View more
  3 in total

1.  Combined photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy: a 2-year result and systematic review.

Authors:  Meng Zhao; Hai-Ying Zhou; Jun Xu; Feng Zhang; Wen-Bin Wei; Ning-Pu Liu
Journal:  Int J Ophthalmol       Date:  2017-03-18       Impact factor: 1.779

Review 2.  Polypoidal choroidal vasculopathy: Pearls in diagnosis and management.

Authors:  Giridhar Anantharaman; Jay Sheth; Muna Bhende; Raja Narayanan; Sundaram Natarajan; Anand Rajendran; George Manayath; Parveen Sen; Rupak Biswas; Alay Banker; Charu Gupta
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

3.  "Double-layer sign" on spectral domain optical coherence tomography in pachychoroid spectrum disease.

Authors:  Jay Sheth; Giridhar Anantharaman; Shruti Chandra; Sobha Sivaprasad
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.